Biocon’s nationwide ‘Winning with Diabetes’ Campaign Raises Awareness on Disease Prevention & Management
Biocon Ltd., Asia’s premier bio pharmaceuticals enterprise and the largest Indian Insulin Company, has scaled up its ‘Winning with Diabetes’ program through a nationwide disease awareness campaign to observe World Diabetes Day (Nov 14th).
The Company aims to reach out to over 100,000 diabetes patients and engage with more than 550 healthcare professionals in over 100 cities across the country as a part of this campaign. Multiple Diabetes Detection Camps, Patient Education Programs and Walkathons are being held to create awareness about diabetes, its prevention and management.
The Patient Education Programs have been designed to educate the common man about the causes, effects, diagnosis and treatment of diabetes, which affects over 65 million people in India currently.
Leading doctors of Hyderabad joined hands with the Company in this initiative to create awareness about diabetes management.
Commenting on this campaign, Mr Partha Roy Chowdhury, Head-Metabolics Division, Biocon said: “Biocon has been making a difference to the lives of millions of diabetics for over a decade now. As a compassionate, caring and responsible company our efforts are aimed at raising awareness about managing the disease through a holistic diabetes management and lifestyle modification program. Our endeavour is to empower many more ‘people with diabetes’ with the ability to ‘win with diabetes’ through lifestyle modification, nutrition management and regular exercise.”
Biocon had introduced India’s first indigenously developed Insulin in 2004 along with its unique patient-centric program ‘Winning with Diabetes,’ involving its team of Field Scientific Officers who counselpatients on managing their life with diabetes.The programfocuses on partnering with the medical fraternity to sensitize and educate diabeticson self-help methods including monitoring of blood glucose, exercise and dietary routines in addition to providing helpful tips to maintain a healthy lifestyle.
Diabetes is a metabolic disorder in which a person has high blood glucose (blood sugar) either because insulin production is inadequate or because the body’s cells do not respond properly to insulin, or both. It is estimated that the number of people with diabetes in India could cross 100 million* by 2035 from 65 million in 2013.
* Source: IDF
About Biocon: Winning with Diabetes
Biocon Limited, publicly listed in 2004, is India’s largest and fully-integrated, innovation-led biopharmaceutical company. As an emerging global biopharmaceutical enterprise serving customers in over 100 countries, it is committed to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer.
For more information: visit:www.biocon.com
